Highbridge Capital Management’s BioTelemetry, Inc. BEAT Stock Holding History

Highbridge Capital Management’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-25,289	Closed	-$413K	–	1921
2016 Q2	$413K	Buy	25,289 +11,252	+80%	+$166K	0.01%	925
2016 Q1	$164K	Buy	+14,037	New	+$157K	﹤0.01%	1371
2015 Q4	–	Sell	-14,882	Closed	-$182K	–	2081
2015 Q3	$182K	Sell	14,882 -4,905	-25%	-$62.5K	﹤0.01%	1387
2015 Q2	$187K	Buy	19,787 +7,521	+61%	+$69.6K	﹤0.01%	1303
2015 Q1	$108K	Sell	12,266 -35,784	-74%	-$362K	﹤0.01%	1310
2014 Q4	$482K	Buy	48,050 +35,807	+292%	+$307K	0.01%	830
2014 Q3	$83K	Sell	12,243 -44,141	-78%	-$310K	﹤0.01%	1152
2014 Q2	$404K	Sell	56,384 -16,519	-23%	-$131K	﹤0.01%	792
2014 Q1	$735K	Sell	72,903 -52,287	-42%	-$481K	0.01%	619
2013 Q4	$994K	Buy	+125,190	New	+$1.17M	0.01%	536

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Highbridge Capital Management's BEAT Position: Q3 2016 in Review

Highbridge Capital Management sold out of BioTelemetry, Inc. (BEAT) in Q3 2016, closing a stake of 25,289 shares — an estimated $413K sold.

Highbridge Capital Management first reported a position in BEAT in Q4 2013 and held it in 10 quarters. The position peaked at $994K in Q4 2013. 167 funds tracked by Wall St. Rank hold BEAT as of Q3 2016.

Highbridge Capital Management reported no remaining BioTelemetry, Inc. position as of Q3 2016 after selling out during the quarter.
Highbridge Capital Management sold 25,289 BioTelemetry, Inc. shares in Q3 2016, an estimated $413K.
Highbridge Capital Management first reported a position in BioTelemetry, Inc. in Q4 2013 and held it in 10 quarters.
Highbridge Capital Management's BioTelemetry, Inc. position peaked at $994K in Q4 2013.
167 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2016.

Based on Highbridge Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.